News

The protective effect of varicella zoster virus vaccine may be hindered in older patients with untreated depression, results of a study indicate.

Patients with rheumatoid arthritis who use anti-tumor necrosis factor (TNF) therapy are not at an increased risk of herpes zoster, according to a recent study.

Women who regularly take aspirin have a 21 percent lower risk of developing melanoma than those who do not take the drug, results of a recent study indicate.

The Food and Drug Administration has approved Lymphoseek, a radioactive diagnostic imaging agent to locate lymph nodes in patients with certain cancers, including melanoma.

The total amount of fraud recoveries returned to Medicare trust funds since the start of the Obama administration is $10.7 billion. [Infographic]

Novan Therapeutics is conducting research on its SB204 drug candidate, which could lead to topical therapies to reduce sebum production.

Traditional teaching about celiac disease (CD) ignores the wide spectrum of this condition, which affects many atopic patients, a clinician says.

Patients who have severe psoriasis and fail conventional therapies can choose from biologic regimens that increasingly match drug attributes with individual patient characteristics, an expert says.

Dermatologists can provide value in the era of healthcare reform by realistically gauging the cost-effectiveness of many treatment strategies, according to an expert who spoke at the 71st annual meeting of the American Academy of Dermatology in Miami Beach, Fla.

Isotretinoin does not appear to be linked to an increased risk of inflammatory bowel disease, researchers report.

A strain of Propionibacterium acnes may contain properties that protect the skin from harmful bacteria, results of a study indicate.

A genetically modified protein demonstrated a reversal of vitiligo in lab mice and could lead to therapies for the condition in human patients.

A new smartphone application from the American Academy of Dermatology provides evidence-based clinical guidelines for treating patients with psoriasis and psoriatic arthritis.

Follow @DermTimesNow on Twitter and hashtag #AAD13 to follow the American Academy of Dermatology meeting in Miami. And take a look at our infographic about attendance.

PuriCore, a water-based clean technology company, has entered into a marketing partnership with Onset Dermatologics.

The Cutaneous Lymphoma Foundation has launched a research awards program aimed at funding innovative research for the disease.

The American Academy of Dermatology Association’s board of directors has unanimously approved a position statement on anatomic pathology billing.

More states and municipalities are considering enacting laws that would restrict minors from using indoor tanning facilities.

Valeant Pharmaceuticals has acquired the rights to Targretin (bexarotene) gel and capsules from Eisai for $65 million.

Legal action related to cutaneous laser procedures have increased significantly in the past three decades, according to results of a recent study, and even doctors who aren’t personally handling the devices are being named in litigation.

Treating facial rhytids may require botulinum toxin doses as much as five times higher in the upper facial muscles than the lower facial muscles, according to findings of a recent study.

The asthma medication omalizumab helps to calm chronic urticaria in patients who had failed standard therapy, according to results of a phase 3 study.

Most tanning salons in Missouri would allow children as young as age 10 to tan if there were no legal restrictions against doing so, according to results of a survey conducted by researchers.

Papules and pustules after patients undergo resurfacing procedures with a fractional CO2 laser may be caused by nontuberculous mycobacterial infection, according to a recent study.

Acute skin infections responded as well to a six-day course of a new antibiotic as infections treated with a longer treatment with an existing drug, researchers report.

Solta Medical will acquire Sound Surgical Technologies for $25.5 million in stock and $5 million in cash, the company announced.

The Food and Drug Administration has approved the topical acne drug Epiduo (adapalene 01. percent/benzoyl peroxide 2.5 percent, Galderma) in children ages 9 and older, according to a news release.

Dermatology Times is heading to Miami Beach for the 71st annual American Academy of Dermatology Conference. This year, we’ll bring you as much up-to-the-minute coverage as possible from a variety of sessions and forums.

Most patients believe it’s not necessary to use sunscreen or other sun protection measures while driving, according to results of a retrospective survey.

A microneedle technique tested by researchers can deliver dried live vaccines into the skin. The method may prove useful for developing countries, as it eliminates the need for needles or refrigeration.